Table 1 Prevalence of CHEK2 1100delC in sporadic and familial breast cancer and controls
From: CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
CHEK2 1100delC+/total tested | p-value1 | |
|---|---|---|
Familial Risk Cohort | 6/311 (1.9%) | 0.09 |
Population-based Cohort | 5/452 (1.1%) | 0.51 |
Sporadic breast cancer | 1/313 (0.3%) | 0.68 |
Familial Breast Cancer | 4/139 (2.9%) | 0.04 |
All Familial patients | 10/450 (2.2%) | 0.03 |
Controls | 5/760 (0.7%) |